Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Interplay between lipids and branched-chain amino acids in development of insulin resistance.

Newgard CB.

Cell Metab. 2012 May 2;15(5):606-14. doi: 10.1016/j.cmet.2012.01.024. Review.

2.

Mechanisms for insulin resistance: common threads and missing links.

Samuel VT, Shulman GI.

Cell. 2012 Mar 2;148(5):852-71. doi: 10.1016/j.cell.2012.02.017. Review.

3.

Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.

Adams SH.

Adv Nutr. 2011 Nov;2(6):445-56. doi: 10.3945/an.111.000737. Epub 2011 Nov 3. Review.

4.

Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet.

Munro IA, Garg ML.

Br J Nutr. 2012 Oct 28;108(8):1466-74. doi: 10.1017/S0007114511006817. Epub 2012 Jan 3.

PMID:
22214842
5.

n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes.

Kromhout D, Geleijnse JM, de Goede J, Oude Griep LM, Mulder BJ, de Boer MJ, Deckers JW, Boersma E, Zock PL, Giltay EJ.

Diabetes Care. 2011 Dec;34(12):2515-20. doi: 10.2337/dc11-0896.

6.

Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet.

Kus V, Flachs P, Kuda O, Bardova K, Janovska P, Svobodova M, Jilkova ZM, Rossmeisl M, Wang-Sattler R, Yu Z, Illig T, Kopecky J.

PLoS One. 2011;6(11):e27126. doi: 10.1371/journal.pone.0027126. Epub 2011 Nov 3.

7.

Effects of dietary fish oil on the depletion of carcinogenic PAH-DNA adduct levels in the liver of B6C3F1 mouse.

Zhou GD, Zhu H, Phillips TD, Wang J, Wang SZ, Wang F, Amendt BA, Couroucli XI, Donnelly KC, Moorthy B.

PLoS One. 2011;6(10):e26589. doi: 10.1371/journal.pone.0026589. Epub 2011 Oct 31.

8.

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.

Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, Ramachandran A, Riddle M, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein H; TIDE Trial Investigators.

Diabetologia. 2012 Jan;55(1):36-45. doi: 10.1007/s00125-011-2357-4. Epub 2011 Oct 29.

PMID:
22038523
9.

Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance.

Lee YS, Li P, Huh JY, Hwang IJ, Lu M, Kim JI, Ham M, Talukdar S, Chen A, Lu WJ, Bandyopadhyay GK, Schwendener R, Olefsky J, Kim JB.

Diabetes. 2011 Oct;60(10):2474-83. doi: 10.2337/db11-0194. Epub 2011 Sep 12.

10.

The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice.

Hensler M, Bardova K, Jilkova ZM, Wahli W, Meztger D, Chambon P, Kopecky J, Flachs P.

Lipids Health Dis. 2011 Aug 2;10:128. doi: 10.1186/1476-511X-10-128.

11.

Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids.

Flachs P, Rühl R, Hensler M, Janovska P, Zouhar P, Kus V, Macek Jilkova Z, Papp E, Kuda O, Svobodova M, Rossmeisl M, Tsenov G, Mohamed-Ali V, Kopecky J.

Diabetologia. 2011 Oct;54(10):2626-38. doi: 10.1007/s00125-011-2233-2. Epub 2011 Jul 21.

PMID:
21779874
12.

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

Han MS, Lim YM, Quan W, Kim JR, Chung KW, Kang M, Kim S, Park SY, Han JS, Park SY, Cheon HG, Dal Rhee S, Park TS, Lee MS.

J Lipid Res. 2011 Jun;52(6):1234-46. doi: 10.1194/jlr.M014787. Epub 2011 Mar 28.

13.

Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus.

Reyes-Soffer G, Rondon-Clavo C, Ginsberg HN.

Expert Opin Pharmacother. 2011 Jun;12(9):1429-38. doi: 10.1517/14656566.2011.563506. Epub 2011 Mar 23. Review.

PMID:
21426238
14.

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, Davis KE, Bikman BT, Halberg N, Rutkowski JM, Wade MR, Tenorio VM, Kuo MS, Brozinick JT, Zhang BB, Birnbaum MJ, Summers SA, Scherer PE.

Nat Med. 2011 Jan;17(1):55-63. doi: 10.1038/nm.2277. Epub 2010 Dec 26.

15.

Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity.

Błachnio-Zabielska A, Zabielski P, Baranowski M, Gorski J.

Lipids. 2011 Mar;46(3):229-38. doi: 10.1007/s11745-010-3515-z. Epub 2010 Dec 22.

16.

Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats.

Hsiao G, Chapman J, Ofrecio JM, Wilkes J, Resnik JL, Thapar D, Subramaniam S, Sears DD.

Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E164-74. doi: 10.1152/ajpendo.00219.2010. Epub 2010 Oct 19.

17.

AMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids.

Jelenik T, Rossmeisl M, Kuda O, Jilkova ZM, Medrikova D, Kus V, Hensler M, Janovska P, Miksik I, Baranowski M, Gorski J, Hébrard S, Jensen TE, Flachs P, Hawley S, Viollet B, Kopecky J.

Diabetes. 2010 Nov;59(11):2737-46. doi: 10.2337/db09-1716. Epub 2010 Aug 6.

18.

Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis.

Sato A, Kawano H, Notsu T, Ohta M, Nakakuki M, Mizuguchi K, Itoh M, Suganami T, Ogawa Y.

Diabetes. 2010 Oct;59(10):2495-504. doi: 10.2337/db09-1554. Epub 2010 Aug 3.

19.

Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.

Arnold C, Konkel A, Fischer R, Schunck WH.

Pharmacol Rep. 2010 May-Jun;62(3):536-47. Review.

20.

alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.

Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, Natali A, Ferrannini E; RISC Study Group.

PLoS One. 2010 May 28;5(5):e10883. doi: 10.1371/journal.pone.0010883.

Supplemental Content

Support Center